Treatment limitations of current immunosuppressive therapies, and growing understanding of psoriasis pathogenesis on a molecular level have stimulated much interest in the field of immunomodulatory therapy for management of psoriasis. Genetic engineering has allowed the development of proteins that are targeted to specific cell surface receptors. A well over 40 tergeted biologic agents are in p…